ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
rdf:type |
node1 |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
rdf:type |
prov:Person |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
owl:sameAs |
https://semopenalex.org/author/A5081090897 |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
http://www.w3.org/ns/org#memberOf |
ripekg:organization/RIPEOBC4BFC02A34DA40BAllergan, Inc |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
foaf:familyName |
Nardo |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
foaf:givenName |
Christopher |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |
foaf:name |
Christopher Nardo |
ripekg:work/10.1016%2Fj.eururo.2013.04.001OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
dcterms:creator |
ripekg:author/RIPEAU7B968040BB7F5104Christopher Nardo |